The Japanese Embassy and Center for Health Solutions and Innovations (CHSI) Philippines recently announced a partnership to provide an ultralight, compact, battery-powered and portable digital X ray machine or FDR Xair to the local government of Olongapo in support of the government’s continuing efforts to combat tuberculosis (TB) in the country.
The donation, facilitated by CHSI Philippines, aims to bolster screening, early detection, and eradication of TB. The FDR Xair, a state-of-the-art portable X-ray system, is instrumental in early TB detection. Its portability and high image quality allow healthcare professionals to perform rapid and accurate screenings in various settings, particularly in remote and underserved communities. By deploying these devices nationwide, FUJIFILM is closing healthcare access gaps and enhancing diagnostic accuracy.
According to 2022 data from the Department of Health (DOH), TB claims the lives of approximately 106 Filipinos daily. FUJIFILM’s innovative solutions, such as the FDR Xair, align with global efforts to reach, cure, and prevent TB in the Philippines. This portable device revolutionizes TB screening with its reliable performance, ease of use, and advanced imaging technology, making it particularly effective in areas with limited healthcare infrastructure.
In March 2023, FUJIFILM Philippines conducted its first Medical Mission and TB screening in Majayjay, Laguna, using their FDR nano and FDR Go Plus systems. The company plans to make this an annual program, continuing to utilize the FDR Xair to provide equitable and sustainable TB interventions. This year, FUJIFILM will make TB screening using FDR Xair available for free at the regular Makati Lingkod Bayan Caravan.
FUJIFILM recognizes the importance of a coordinated, multi-sectoral approach to tackle the global challenge of TB. By partnering with governments, international organizations, civil society, and the private sector, FUJIFILM aims to build a healthier, TB-free future.
With over 600,000 TB cases reported by the DOH as of December 31, 2023, the urgency for enhanced detection capabilities and coordinated efforts has never been greater. Despite the severity of TB, it remains curable with free medication available at TB DOTS clinics nationwide.
